Morphological and cellular basis for airflow limitation in smokers

Airflow limitation has two well-defined components, increased resistance, which is found predominantly in the small airways, and loss of elastic recoil. Small airways contribute to the increased resistance to flow by the narrowing of the airway lumen. Morphometric studies have shown that smokers have increased epithelial abnormalities, cellular inflammatory infiltrates in the airway wall, increased muscle and fibrosis, when compared with nonsmokers. Along with these anatomical changes, an increased percentage of airways < 400 microns in diameter is found. In addition to the measured changes, other nonmeasurable, dynamic events occur in the airways of smokers, which further decrease lumen diameter. There is ample evidence to show that the airways of smokers react to nonspecific stimuli by constricting, which results in increased resistance and decreased forced expiratory volume in one second (FEV1). The pathological changes found in smokers, that could be responsible for active muscle constriction and airway narrowing include: 1) airway epithelial damage, resulting in increased permeability and impairment of other epithelial function; 2) chronic airway inflammation; 3) structural changes in the airway wall; and 4) loss of alveolar attachments. However, not all smokers develop the abovementioned airway abnormalities. We describe how smokers could develop either centrilobular emphysema (CLE), or panlobular emphysema (PLE). We have found that smokers with CLE have more abnormal and narrower small airways, and flow limitation is correlated with the small airway abnormalities and not with loss of recoil. In contrast, smokers with PLE have much less severe airway abnormalities, diffuse emphysema that can be detected microscopically at a stage when FEV1 might be only mildly abnormal, and early changes in elastic recoil as evidenced by the changes in the pressure-volume curve of the lung. Furthermore, in PLE, airflow limitation is correlated with loss of recoil but not with abnormalities in the small airways. We believe that the mechanisms involved in the pathogenesis of the two types of emphysema in smokers are different; an airborne mechanism for CLE, possibly related to airway hyperresponsiveness, and a bloodborne mechanism for PLE, which may be related to dysfunction of alpha 1-antiproteases. We conclude that the separation of smokers based on their emphysema type is essential if we are to understand the pathogenesis of chronic obstructive pulmonary disease (COPD) in these subjects.

This article has been cited by other articles:

				D. Massaro and G. D. Massaro Apoetm1Unc mice have impaired alveologenesis, low lung function, and rapid loss of lung function Am J Physiol Lung Cell Mol Physiol, May 1, 2008; 294(5): L991 - L997. [Abstract] [Full Text] [PDF]

				I Sabroe, L C Parker, P M A Calverley, S K Dower, and M K B Whyte Pathological networking: a new approach to understanding COPD Postgrad. Med. J., May 1, 2008; 84(991): 259 - 264. [Abstract] [Full Text] [PDF]

				I. Sabroe, L. C Parker, P. M A Calverley, S. K Dower, and M. K B Whyte Pathological networking: a new approach to understanding COPD Thorax, August 1, 2007; 62(8): 733 - 738. [Abstract] [Full Text] [PDF]

				M Skogstad, K Kjaerheim, G Fladseth, M Gjolstad, H L Daae, R Olsen, P Molander, and D G Ellingsen Cross shift changes in lung function among bar and restaurant workers before and after implementation of a smoking ban Occup. Environ. Med., July 1, 2006; 63(7): 482 - 487. [Abstract] [Full Text] [PDF]

				R O'Donnell, D Breen, S Wilson, and R Djukanovic Inflammatory cells in the airways in COPD Thorax, May 1, 2006; 61(5): 448 - 454. [Abstract] [Full Text] [PDF]

				K. F. Chung The Role of Airway Smooth Muscle in the Pathogenesis of Airway Wall Remodeling in Chronic Obstructive Pulmonary Disease Proceedings of the ATS, November 1, 2005; 2(4): 347 - 354. [Abstract] [Full Text] [PDF]

				A. I. D'hulst, K. Y. Vermaelen, G. G. Brusselle, G. F. Joos, and R. A. Pauwels Time course of cigarette smoke-induced pulmonary inflammation in mice Eur. Respir. J., August 1, 2005; 26(2): 204 - 213. [Abstract] [Full Text] [PDF]

				A. L. James, L. J. Palmer, E. Kicic, P. S. Maxwell, S. E. Lagan, G. F. Ryan, and A. W. Musk Decline in Lung Function in the Busselton Health Study: The Effects of Asthma and Cigarette Smoking Am. J. Respir. Crit. Care Med., January 15, 2005; 171(2): 109 - 114. [Abstract] [Full Text] [PDF]

				S. Fuke, T. Betsuyaku, Y. Nasuhara, T. Morikawa, H. Katoh, and M. Nishimura Chemokines in Bronchiolar Epithelium in the Development of Chronic Obstructive Pulmonary Disease Am. J. Respir. Cell Mol. Biol., October 1, 2004; 31(4): 405 - 412. [Abstract] [Full Text] [PDF]

				R. D. Wang, H. Tai, C. Xie, X. Wang, J. L. Wright, and A. Churg Cigarette Smoke Produces Airway Wall Remodeling in Rat Tracheal Explants Am. J. Respir. Crit. Care Med., November 15, 2003; 168(10): 1232 - 1236. [Abstract] [Full Text] [PDF]

				N. Jakeways, T. McKeever, S.A. Lewis, S.T. Weiss, and J. Britton Relationship between FEV1 reduction and respiratory symptoms in the general population Eur. Respir. J., April 1, 2003; 21(4): 658 - 663. [Abstract] [Full Text] [PDF]

				M. Saetta and G. Turato Airway pathology in asthma Eur. Respir. J., July 2, 2001; 18(34_suppl): 18S - 23s. [Abstract] [Full Text] [PDF]

				M. SAETTA, G. TURATO, S. BARALDO, A. ZANIN, F. BRACCIONI, C. E. MAPP, P. MAESTRELLI, G. CAVALLESCO, A. PAPI, and L. M. FABBRI Goblet Cell Hyperplasia and Epithelial Inflammation in Peripheral Airways of Smokers with Both Symptoms of Chronic Bronchitis and Chronic Airflow Limitation Am. J. Respir. Crit. Care Med., March 1, 2000; 161(3): 1016 - 1021. [Abstract] [Full Text] [PDF]

				S. R Rutgers, D. S Postma, N. H T ten Hacken, H. F Kauffman, T. W van der Mark, G. H Koëter, and W. Timens Ongoing airway inflammation in patients with COPD who do not currently smoke Thorax, January 1, 2000; 55(1): 12 - 18. [Abstract] [Full Text]

				M. SAETTA Airway Inflammation in Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): S17 - 20. [Abstract] [Full Text] [PDF]

				F. E. HARGREAVE and R. LEIGH Induced Sputum, Eosinophilic Bronchitis, and Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., November 1, 1999; 160(5): S53 - 57. [Abstract] [Full Text] [PDF]

				M. KOHLHÄUFL, P. BRAND, C. ROCK, T. RADONS, G. SCHEUCH, T. MEYER, H. SCHULZ, K. J. PFEIFER, K. HÄUSSINGER, and J. HEYDER Noninvasive Diagnosis of Emphysema . Aerosol Morphometry and Aerosol Bolus Dispersion in Comparison to HRCT Am. J. Respir. Crit. Care Med., September 1, 1999; 160(3): 913 - 918. [Abstract] [Full Text]

				M. SAETTA, S. BARALDO, L. CORBINO, G. TURATO, F. BRACCIONI, F. REA, G. CAVALLESCO, G. TROPEANO, C. E. MAPP, P. MAESTRELLI, et al. CD8+ve Cells in the Lungs of Smokers with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., August 1, 1999; 160(2): 711 - 717. [Abstract] [Full Text]

				P J STERK, H W F M DE GOUW, F L M RICCIARDOLO, and K F RABE Exhaled nitric oxide in COPD: glancing through a smoke screen Thorax, July 1, 1999; 54(7): 565 - 567. [Full Text]

				R. A. Pauwels, C.-G. Lofdahl, L. A. Laitinen, J. P. Schouten, D. S. Postma, N. B. Pride, S. V. Ohlsson, and The European Respiratory Society Study on Chronic Long-Term Treatment with Inhaled Budesonide in Persons with Mild Chronic Obstructive Pulmonary Disease Who Continue Smoking N. Engl. J. Med., June 24, 1999; 340(25): 1948 - 1953. [Abstract] [Full Text] [PDF]

				M. SAETTA, A. Di STEFANO, G. TURATO, F. M. FACCHINI, L. CORBINO, C. E. MAPP, P. MAESTRELLI, A. CIACCIA, and L. M. FABBRI CD8+ T-Lymphocytes in Peripheral Airways of Smokers with Chronic Obstructive Pulmonary Disease Am. J. Respir. Crit. Care Med., March 1, 1998; 157(3): 822 - 826. [Abstract] [Full Text] [PDF]

				D. Harrison, A. Cantlay, F. Rae, D. Lamb, and C. Smith Frequency of glutathione S-transferase M1 deletion in smokers with emphysema and lung cancer Human and Experimental Toxicology, July 1, 1997; 16(7): 356 - 360. [Abstract] [PDF]